Press Release Details

View all news

Inspire Medical Systems, Inc. to Report Third Quarter 2022 Financial Results on November 1, 2022

October 04, 2022

MINNEAPOLIS, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2022 after the close of trading on Tuesday, November 1. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

To access the call, please use the following link: Inspire's Q3 2022 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

A simultaneous webcast of the call will be accessible via the Investor Relations page of the Inspire’s website at For those not planning to ask a question of management, the Company recommends listening via the webcast.

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations

Primary Logo

Source: Inspire Medical Systems, Inc.
Categories: Press Releases
View all news